The partnership is modeled after Fresenius’s existing programs for more than 10,000 end-stage renal disease patients and more than 5,000 chronic kidney disease patients across the U.S. Under the agreement with CHS, Fresenius will manage identification, staging and care coordination for patients with renal disease.
These patients often have multiple comorbidities and make up a large chunk of ACO spending. The collaboration will help rein in these costs of care and improve outcomes for renal disease patients.
“Not only do renal patients have complex needs, they are a difficult group to identify, making it challenging for providers in ACOs to coordinate their care. We look forward to working with Fresenius Medical Care as we discover new ways to improve the care quality of this important population,” Jeff Spight, president of CHS, said in a press release.
More articles on accountable care:
Doylestown Health, Holy Redeemer plan to roll out Medicare ACO in 2017
UNC Health, Cigna launch collaborative care initiative
How should ACOs choose hospital partners?
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.